GWP
TMO icon

Gen-Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Gen-Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$133K Sell
265
-290
-52% -$139K 0.04% 291
2026
Q1 		$273K Sell
555
-501
-47% -$272K 0.09% 219
2025
Q4 		$612K Sell
1,056
-861
-45% -$487K 0.2% 99
2025
Q3 		$930K Sell
1,917
-245
-11% -$114K 0.31% 76
2025
Q2 		$877K Buy
2,162
+569
+36% +$238K 0.34% 83
2025
Q1 		$792K Buy
1,593
+269
+20% +$146K 0.33% 88
2024
Q4 		$689K Buy
1,324
+302
+30% +$166K 0.3% 87
2024
Q3 		$562K Buy
1,022
+323
+46% +$191K 0.25% 110
2024
Q2 		$387K Buy
699
+139
+25% +$79.6K 0.19% 137
2024
Q1 		$325K Buy
+560
New +$314K 0.16% 147

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Gen-Wealth Partners's TMO Position: Q2 2026 in Review

Gen-Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 52% in Q2 2026, selling an estimated $139K and leaving 265 shares worth $133K. The position accounts for 0.04% of the portfolio, ranked #291.

Gen-Wealth Partners first reported a position in TMO in Q1 2024 and has held it in 10 quarters since. The position peaked at $930K in Q3 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Gen-Wealth Partners held 265 shares of Thermo Fisher Scientific worth $133K as of Q2 2026.
  • Gen-Wealth Partners sold 290 Thermo Fisher Scientific shares in Q2 2026, an estimated $139K.
  • Thermo Fisher Scientific made up 0.04% of Gen-Wealth Partners's portfolio in Q2 2026, its #291 holding.
  • Gen-Wealth Partners first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 10 quarters since.
  • Gen-Wealth Partners's Thermo Fisher Scientific position peaked at $930K in Q3 2025.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.